Citadel Advisors’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,500
| Closed | -$12.4K | – | 15438 |
|
|
2023
Q2 | $12.4K | Sell |
1,500
-1,100
| -42% | -$6.58K | ﹤0.01% | 13081 |
|
|
2023
Q1 | $14.5K | Buy |
+2,600
| New | +$14.9K | ﹤0.01% | 13302 |
|
|
2022
Q3 | – | Sell |
-15,200
| Closed | -$39K | – | 13942 |
|
|
2022
Q2 | $39K | Buy |
+15,200
| New | +$57K | ﹤0.01% | 12082 |
|
|
2022
Q1 | – | Sell |
-19,100
| Closed | -$287K | – | 14928 |
|
|
2021
Q4 | $287K | Sell |
19,100
-26,700
| -58% | -$486K | ﹤0.01% | 11026 |
|
|
2021
Q3 | $1.2M | Sell |
45,800
-4,700
| -9% | -$173K | ﹤0.01% | 7679 |
|
|
2021
Q2 | $2.52M | Buy |
50,500
+13,800
| +38% | +$618K | ﹤0.01% | 6016 |
|
|
2021
Q1 | $1.69M | Sell |
36,700
-1,000
| -3% | -$47.7K | ﹤0.01% | 6807 |
|
|
2020
Q4 | $1.61M | Buy |
37,700
+16,600
| +79% | +$630K | ﹤0.01% | 5831 |
|
|
2020
Q3 | $860K | Sell |
21,100
-1,000
| -5% | -$49.8K | ﹤0.01% | 6301 |
|
|
2020
Q2 | $1.21M | Buy |
22,100
+9,900
| +81% | +$566K | ﹤0.01% | 5478 |
|
|
2020
Q1 | $638K | Buy |
12,200
+6,300
| +107% | +$341K | ﹤0.01% | 6086 |
|
|
2019
Q4 | $287K | Sell |
5,900
-3,700
| -39% | -$173K | ﹤0.01% | 7653 |
|
|
2019
Q3 | $527K | Buy |
9,600
+4,600
| +92% | +$263K | ﹤0.01% | 6649 |
|
|
2019
Q2 | $250K | Buy |
+5,000
| New | +$249K | ﹤0.01% | 7862 |
|
Other funds holding TRHC
Citadel Advisors's TRHC Position: Q4 2023 in Review
Citadel Advisors sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 296 shares — an estimated $3.05K sold.
Citadel Advisors first reported a position in TRHC in Q4 2017 and held it in 17 quarters. The position peaked at $5.11M in Q2 2021. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- Citadel Advisors reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 296 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $3.05K.
- Citadel Advisors first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 17 quarters.
- Citadel Advisors's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $5.11M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.